[1]鲁 冰,任东升,陶雅非,等.维持性血液透析与持续不卧床腹膜透析对终末期肾病患者钙磷代谢及氧化应激的影响比较[J].新乡医学院学报,2022,39(9):833-837.[doi:10.7683/xxyxyxb.2022.09.007]
 LU Bing,REN Dongsheng,TAO Yafei,et al.Comparison of the effect of maintenance hemodialysis and continuous ambulatory peritoneal dialysis on calcium and phosphorus metabolism and oxidative stress in patients with end-stage renal disease[J].Journal of Xinxiang Medical University,2022,39(9):833-837.[doi:10.7683/xxyxyxb.2022.09.007]
点击复制

维持性血液透析与持续不卧床腹膜透析对终末期肾病患者钙磷代谢及氧化应激的影响比较
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年9
页码:
833-837
栏目:
临床研究
出版日期:
2022-09-05

文章信息/Info

Title:
Comparison of the effect of maintenance hemodialysis and continuous ambulatory peritoneal dialysis on calcium and phosphorus metabolism and oxidative stress in patients with end-stage renal disease
作者:
鲁 冰任东升陶雅非王建刚
(南阳市中心医院肾内科,河南 南阳 473005)
Author(s):
LU BingREN DongshengTAO YafeiWANG Jiangang
(Department of Nephrology,Nanyang Central Hospital,Nanyang 473005,Henan Province,China)
关键词:
终末期肾病血液透析腹膜透析钙磷代谢氧化应激
Keywords:
end-stage renal diseasehemodialysisperitoneal dialysiscalcium and phosphorus metabolismoxidative stress
分类号:
R692
DOI:
10.7683/xxyxyxb.2022.09.007
文献标志码:
A
摘要:
目的 探讨维持性血液透析与持续不卧床腹膜透析对终末期肾病患者钙磷代谢及氧化应激的影响。方法 选择2019年1月至2021年10月南阳市中心医院肾内科收治的120例行透析治疗的终末期肾病患者为研究对象,按照随机数字表法将患者分为对照组和观察组,每组60例。对照组患者采用维持性血液透析治疗,观察组患者采用持续不卧床腹膜透析治疗,2组患者均连续治疗3个月。透析治疗前及连续透析治疗3个月后,使用全自动生物化学分析仪检测2组患者的血清钙、磷水平,采用硫代巴比妥酸法检测2组患者血清中丙二醛(MDA)水平,采用黄嘌呤氧化酶法检测2组患者血清中超氧化物歧化酶(SOD)水平,采用比色法检测2组患者血清中髓过氧化物酶(MPO)水平。比较2组患者连续透析治疗3个月后血清钙、磷达标率及透析治疗期间消化道出血、动静脉内瘘闭塞、感染、低蛋白血症及心功能异常等并发症发生情况。结果 透析治疗前,2组患者血清钙、磷及MDA、SOD、MPO水平比较差异均无统计学意义(P>0.05)。透析治疗3个月后,2组患者的血清钙水平及对照组患者的血清磷水平与透析治疗前比较差异无统计学意义(P>0.05),观察组患者的血清磷水平显著低于透析治疗前(P<0.05)。透析治疗3个月后,2组患者的血清钙水平比较差异无统计学意义(P>0.05),观察组患者的血清磷水平显著低于对照组(P<0.05)。对照组患者血清钙达标35例(58.33%),血清磷达标16例(26.67%);观察组患者血清钙达标38例(63.33%),血清磷达标31例(51.67%);2组患者血清钙达标率比较差异无统计学意义(χ2=0.315,P>0.05),观察组患者血清磷达标率显著高于对照组(χ2=7.869,P<0.05)。 透析治疗3个月后,2组患者血清中MDA、MPO水平显著高于透析治疗前(P<0.05),SOD水平显著低于透析治疗前(P<0.05)。透析治疗3个月后,观察组患者血清中MDA、MPO水平显著低于对照组(P<0.05),SOD水平显著高于对照组(P<0.05)。透析治疗期间,对照组患者发生消化道出血4例(6.67%),动静脉内瘘闭塞3例(5.00%),感染2例(3.33%),低蛋白血症4例(6.67%),心功能异常5例(8.33%),并发症发生率为30.00%(18/60);观察组患者发生消化道出血2例(3.33%),动静脉内瘘闭塞1例(1.67%),感染1例(1.67%),低蛋白血症1例(1.67%),心功能异常2例(3.33%),并发症发生率为11.67%(7/60);观察组患者并发症发生率显著低于对照组(χ2=6.114,P<0.05)。结论 维持性血液透析和持续不卧床腹膜透析对终末期肾病患者血清钙代谢的影响无显著差异,而持续不卧床腹膜透析对终末期肾病患者血清磷的控制效果更好,诱发患者机体的氧化应激反应相对更轻微,安全性更高。
Abstract:
Objective To investigate the effect of maintenance hemodialysis and continuous ambulatory peritoneal dialysis on calcium and phosphorus metabolism and oxidative stress in patients with end-stage renal disease.Methods A total of 120 patients with end-stage renal disease who received dialysis treatment in the Department of Nephrology of Nanyang Central Hospital from January 2019 to October 2021 were selected as the research objects,and the patients were divided into the control group and the observation group according to the random number table method,with 60 cases in each group.The patients in the control group were treated with maintenance hemodialysis,and patients in the observation group were treated with continuous ambulatory peritoneal dialysis,the patients in the both groups were treated for 3 months.Before dialysis treatment and after 3 months of continuous dialysis treatment,the serum calcium and phosphorus levels of the patients in the two groups were detected by the automatic biochemical analyzer,the serum malondialdehyde (MDA) level was detected by the thiobarbituric acid method,the serum superoxide dismutase (SOD) level was detected by the xanthine oxidase method,the serum myeloperoxidase (MPO) level was detected by the colorimetric method.The rate of serum calcium and phosphorus reaching the standard before dialysis treatment and after 3 months of continuous dialysis treatment between the two groups were compared,the complications such as hemorrhage of digestive tract,arteriovenous fistula occlusion,infection,hypoalbuminemia and abnormal cardiac function during dialysis treatment were compared between the two groups.Results There was no significant difference in serum calcium,phosphorus,MDA,SOD and MPO levels of patients between the two groups before dialysis treatment (P>0.05).After 3 months of dialysis treatment,there was no significant difference in the serum calcium level of patients between the two groups (P>0.05).There was no significant difference in serum phosphorus level of patients before dialysis treatment and after 3 months of dialysis treatment in the control group(P>0.05).The serum phosphorus level of patients in the observation group after 3 months of dialysis treatment was significantly lower than that before dialysis treatment (P<0.05).There was no significant difference in serum calcium level of patients between the two groups after 3 months of dialysis treatment (P>0.05).After 3 months of dialysis treatment,the serum phosphorus level of patients in the observation group was significantly lower than that in the control group (P<0.05).In the control group,35 cases (58.33%) reached the standard of the serum calcium,and 16 cases (26.67%) reached the standard of the serum phosphorus;in the observation group,38 cases (63.33%) reached the standard of serum calcium,and 31 cases (51.67%) reached the standard of the serum phosphorus;there was no significant difference in the rate of reaching the standard of serum calcium between the two groups (χ2=0.315,P>0.05);the serum phosphorus compliance rate in the observation group was significantly higher than that in the control group(χ2=7.869,P<0.05).After 3 months of dialysis treatment,the serum MDA and MPO levels of patients were significantly higher than those before dialysis treatment in the two groups (P<0.05),and the SOD level of patients was significantly lower than that before dialysis treatment(P<0.05).After 3 months of dialysis treatment,the serum MDA and MPO levels of patients in the observation group were significantly lower than those in the control group(P<0.05),and the serum SOD level of patients was significantly higher than that in the control group(P<0.05).During dialysis treatment,hemorrhage of digestive tract occurred in 4 cases (6.67%),arteriovenous fistula occlusion in 3 cases (5.00%),infection in 2 cases (3.33%),hypoalbuminemia in 4 cases (6.67%),abnormal cardiac function in 5 cases (8.33%),and the incidence of complication was 30.00% (18/60) in the control group;in the observation group,hemorrhage of digestive tract occurred in 2 cases (3.33%),arteriovenous fistula occlusion in 1 case (1.67%),infection in 1 case (1.67%),hypoproteinemia in 1 case (1.67%),cardiac dysfunction in 2 cases (3.33%),and the incidence of complications was 11.67% (7/60);the incidence of complications in the observation group was significantly lower than that in the control group (χ2=6.114,P<0.05).Conclusion The effect of maintenance hemodialysis on the serum calcium metabolism of patients with end-stage renal disease has no significant difference compared with that of continuous ambulatory peritoneal dialysis,but continuous ambulatory peritoneal dialysis has better control for serum phosphorus in patients with end-stage renal disease,and the oxidative stress reaction of patients caused by continuous ambulatory peritoneal dialysis is relatively mild,it has higher security.

参考文献/References:

[1] PAPADOPOULOU A,BOUNTOUVI E,KARACHALIOU F E.The molecular basis of calcium and phosphorus inherited metabolic disorders[J].Genes (Basel),2021,12(5):734-738.
[2] WOUK N.End-stage renal disease:medical management[J].Am Fam Physician,2021,104(5):493-499.
[3] ROUMELIOTIS S,ROUMELIOTIS A,GORNY X,et al.Could antioxidant supplementation delay progression of cardiovascular disea-se in end-stage renal disease patients[J].Curr Vasc Pharmacol,2021,19(1):41-54.
[4] 徐钢.肾脏病诊疗指南[M].北京:科学出版社,2013:27-43.
XU G.Guidelines for diagnosis and treatment of nephropathy[M].Beijing:Science Press,2013:27-43.
[5] 国家肾脏疾病临床医学研究中心.中国慢性肾脏病矿物质和骨异常诊治指南概要[J].肾脏病与透析肾移植杂志,2019,28(1):52-57.
NATIONAL CLINICAL RESEARCH CENTER OF KIDNEY DISEASES.Summary of Chinese guidelines for the diagnosis and treatment of mineral and bone abnormalities in chronic kidney disease[J].J Nephrol Dialy Transplant,2019,28(1):52-57.
[6] RASTOGI A,BHATT N,ROSSETTI S,et al.Management of hyperphosphatemia in end-stage renal disease:a new paradigm[J].J Ren Nutr,2021,31(1):21-34.
[7] TRUYTS C,CUSTODIO M,PECOIT-FILHO R,et al.Cardiovascular mortality in peritoneal dialysis:the impact of mineral disorders[J].J Bras Nefrol,2021,43(2):182-190.
[8] 卢光娅,王淑华,赵子秀,等.腹膜透析与血液透析对尿毒症患者炎症细胞因子及钙磷代谢水平影响的对比研究[J].临床和实验医学杂志,2019,18(13):1417-1420.
LU G Y,WANG S H,ZHAO Z X,et al.A comparative study of the effects of peritoneal dialysis and hemodialysis on inflammatory cytokines and calcium and phosphorus metabolism in uremic patients[J].J Clin Exp Med,2019,18(13):1417-1420.
[9] DEBOWSKA M,GOMEZ R,PINTO J,et al.Phosphate clearance in peritoneal dialysis[J].Sci Rep,2020,10(1):17504-17509.
[10] DIAS D B,MENDES M L,CARAMORI J T,et al.Urgent-start dia-lysis:comparison of complications and outcomes between peritoneal dialysis and haemodialysis[J].Perit Dial Int,2021,41(2):244-252.
[11] RODRIGUES H C N,MARTINS T F P,SANTANA N C F E S,et al.Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients:a randomized,double-blind,placebo-controlled clinical trial[J].Clin Nutr ESPEN,2021,44(11):136-142.
[12] 骆强,卿山林,尧鹏.血液透析、高通量血液透析及血液透析滤过治疗尿毒症患者的效果及对血清炎症因子、氧化应激指标的影响[J].临床误诊误治,2020,33(4):71-76.
LUO Q,QING S L,YAO P.Effects of hemodialysis,high-flux hemodialysis and hemodiafiltration on patients with uremia and its influence on serum inflammatory factors and oxidative stress indexes[J].Clin Misdiag Misther,2020,33(4):71-76.
[13] FORMAN H J,ZHANG H.Targeting oxidative stress in disease:promise and limitations of antioxidant therapy[J].Nat Rev Drug Discov,2021,20(9):689-709.
[14] INNICO G,GOBBI L,BERTOLDI G,et al.Oxidative stress,inflammation,and peritoneal dialysis:a molecular biology approach[J].Artif Organs,2021,45(10):1202-1207.
[15] ROUMELIOTIS S,DOUNOUSI E,SALMAS M,et al.Unfavorable effects of peritoneal dialysis solutions on the peritoneal membrane:the role of oxidative stress[J].Biomolecules,2020,10(5):768-772.
[16] 刘伯英,戴芳,康亚洁,等.腹膜透析与维持性血液透析对终末期肾病患者炎性因子肾功能及氧化应激的影响[J].中国药物与临床,2020,20(23):4011-4013.
LIU B Y,DAI F,KANG Y J,et al.Effects of peritoneal dialysis and maintenance hemodialysis on inflammatory factors,renal function and oxidative stress in patients with end-stage renal disease[J].Chin Remed Clin,2020,20(23):4011-4013.

相似文献/References:

[1]周长菊,章旭,曹娟,等.维持性血液透析患者采用不同血液净化方式心脏瓣膜钙化高危因素分析[J].新乡医学院学报,2012,29(04):000.
[2]任 伟,王玉梅,陈永健.老年糖尿病肾病患者血液透析相关肺炎危险因素分析[J].新乡医学院学报,2021,38(1):076.[doi:10.7683/xxyxyxb.2021.01.017]
 REN Wei,WANG Yumei,CHEN Yongjian.Analysis of the risk factors of hemodialysis associated pneumonia in elderly patients with diabetic nephropathy[J].Journal of Xinxiang Medical University,2021,38(9):076.[doi:10.7683/xxyxyxb.2021.01.017]
[3]汪丽丽,孙娴静,张馨怡,等.罗沙司他联合蔗糖铁和促红细胞生成素治疗血液透析患者肾性贫血疗效观察[J].新乡医学院学报,2021,38(9):818.[doi:10.7683/xxyxyxb.2021.09.004]
 WANG Lili,SUN Xianjing,ZHANG Xinyi,et al.Clinical effect of roxadustat combined with iron sucrose and erythropoietin in the treatment of renal anemia of hemodialysis patients[J].Journal of Xinxiang Medical University,2021,38(9):818.[doi:10.7683/xxyxyxb.2021.09.004]
[4]袁小强,张献朝,赵丽萍.西那卡塞和骨化三醇联合治疗糖尿病肾病血液透析患者继发性甲状旁腺功能亢进症疗效观察[J].新乡医学院学报,2022,39(2):131.[doi:10.7683/xxyxyxb.2022.02.006]
 YUAN Xiaoqiang,ZHANG Xianchao,ZHAO Liping.Effect of cinacalcet and calcitriol in the treatment of secondary hyperparathyroidism in diabetic nephropathy patients undergoing hemodialysis[J].Journal of Xinxiang Medical University,2022,39(9):131.[doi:10.7683/xxyxyxb.2022.02.006]
[5]杨靖倩,狄亚妮,胡爽爽,等.终末期肾病患者腹膜透析后心血管疾病影响因素分析[J].新乡医学院学报,2023,40(4):333.[doi:10.7683/xxyxyxb.2023.04.007]
 YANG Jingqian,DI Yani,HU Shuangshuang,et al.Analysis of influencing factors of cardiovascular disease in patients with end-stage renal disease after peritoneal dialysis[J].Journal of Xinxiang Medical University,2023,40(9):333.[doi:10.7683/xxyxyxb.2023.04.007]
[6]王岩,张爱霞,王紫晖,等.碱性成纤维细胞生长因子、血清和糖皮质激素诱导的蛋白激酶3表达与血液透析患者动静脉内瘘失功的关系[J].新乡医学院学报,2023,40(9):851.[doi:10.7683/xxyxyxb.2023.09.009]
 WANG Yan,ZHANG Aixia,WANG Zihui,et al.Relationship between the expression of basic fibroblast growth factor,serum and glucocorticoid-induced protein kinase 3 and the dysfunction of arteriovenous fistula in patients undergoing hemodialysis[J].Journal of Xinxiang Medical University,2023,40(9):851.[doi:10.7683/xxyxyxb.2023.09.009]
[7]李会宁,黄智敏.高通量血液透析对老年终末期肾病患者氧化应激及微炎症状态的影响[J].新乡医学院学报,2023,40(11):1069.[doi:10.7683/xxyxyxb.2023.11.012]
 LI Huining,HUANG Zhimin.Effect of high-flux hemodialysis on oxidative stress and microinflammatory status in elderly patients with end-stage renal disease[J].Journal of Xinxiang Medical University,2023,40(9):1069.[doi:10.7683/xxyxyxb.2023.11.012]

更新日期/Last Update: 2022-09-05